What is Mesa Science Associates?
Mesa Science Associates, Inc. operates as a high-authority entity within the drug product development sector. The firm provides an end-to-end suite of services, encompassing complex CMC development, clinical study management, and sophisticated drug delivery system engineering. By bridging the gap between early-stage research and final regulatory approval, the company serves as a critical partner for pharmaceutical innovators. As a veteran-owned enterprise, Mesa Science Associates distinguishes itself through a rigorous commitment to safety, compliance, and the delivery of life-changing therapies, effectively positioning itself as a cornerstone in the modern biotech ecosystem.
How much funding has Mesa Science Associates raised?
Mesa Science Associates has raised a total of $31K across 1 funding round:
Debt
$31K
Debt (2021): $31K with participation from PPP
Key Investors in Mesa Science Associates
PPP
Public-Private Partnership
What's next for Mesa Science Associates?
With the infusion of this latest capital, Mesa Science Associates is poised to scale its infrastructure and broaden its service portfolio. The strategic focus will likely shift toward enhancing its pharmacology and device development capabilities to meet the increasing demand for complex therapeutic solutions. By leveraging this financial backing, the company is expected to optimize its project management frameworks, ensuring that it remains at the forefront of regulatory excellence and scientific innovation. This growth phase is critical for the firm as it seeks to solidify its market share and continue its trajectory of supporting high-stakes pharmaceutical projects from inception to commercialization.
See full Mesa Science Associates company page
